Skip to content

Clinical trials

Active, not recruiting Carcinoma, Non-Small-Cell Lung trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Active, not recruiting Country / region: South Korea Clear all

126 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20154
20166
20178
20188
201915
202012
202115
202223
202320
202412
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting126

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca24
Janssen Research & Development, LLC10
Eli Lilly and Company7
Merck Sharp & Dohme LLC7
Hoffmann-La Roche6
Novartis Pharmaceuticals6
Daiichi Sankyo5
AbbVie4
GlaxoSmithKline4
EMD Serono Research & Development Institute, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung126
Lung Neoplasms17
Colorectal Neoplasms16
Neoplasms15
Neoplasm Metastasis14
Melanoma8
Ovarian Neoplasms8
Breast Neoplasms7
Head and Neck Neoplasms7
Pancreatic Neoplasms7

Trials

Showing 1 to 25 of 126. Each trial links to its page on Pharma Observatory.

26 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.